Targeting SHP2 further sensitized pancreatic cancer cells to MEK inhibition and promoted a senescence response in KRAS-mutant non-small cell lung cancer models under nutrient-restricted conditions (130, 131). This evidence concerns the gene KRAS and non-small cell lung carcinoma.